drugset / Trial / NCT05779514
Effect of Mirabegron on Promoting Brown Adipose Tissue Activation
NaSingle-groupOpen-labelTreatment
Summary
In previous preclinical studies, our group found that Mirabegron, a clinical drug, could activate brown adipose tissue and inhibit tumor growth in tumour-bearing mice.Investigators look forward to further evaluating the effect of Mirabegron-mediated brown adipose tissue activation, so as to provide new drug applications for clinical cancer prevention and treatment
Timeline
- Start
- 2022-08-18
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mirabegron | Other / unclassified | 100 mg | Oral |
| Subject | Mirabegron | Other / unclassified | 200 mg | Oral |